Loading…
Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
Doria, A., Stohl, W., Schwarting, A., Okada, M., Scheinberg, M., Vollenhoven, R., Hammer, A. E., Groark, J., Bass, D., Fox, N. L., Roth, D., Gordon, D.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.08.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.08.2018)
Get full text
Journal Article
Loading…
Loading…
Value of combined detection of anti‑nuclear antibody, anti‑double‑stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus
Qu, Changhua, Zhang, Juan, Zhang, Xiumei, Du, Jiexin, Su, Baifang, Li, Hong
Published in Experimental and therapeutic medicine (01.02.2019)
Published in Experimental and therapeutic medicine (01.02.2019)
Get full text
Journal Article
Loading…
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study
GHIRARDELLO, A, VILLALTA, D, RADICE, A, RICCIERI, V, RUFFATTI, A, SEBASTIANI, G. D, SINICO, R. A, TINCANI, A, DORIA, A, MOROZZI, G, AFELTRA, A, GALEAZZI, M, GERLI, R, MATHIEU, A, MERONI, P. L, PREGNOLATO, F, MIGLIORINI, P
Published in Clinical and experimental rheumatology (2011)
Get full text
Published in Clinical and experimental rheumatology (2011)
Journal Article
Loading…
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements
Putterman, Chaim, Furie, Richard, Ramsey-Goldman, Rosalind, Askanase, Anca, Buyon, Jill, Kalunian, Kenneth, Chatham, W Winn, Massarotti, Elena, Kirou, Kyriakos, Jordan, Nicole, Blanco, Irene, Weinstein, Arthur, Chitkara, Puja, Manzi, Susan, Ahearn, Joseph, O'Malley, Tyler, Conklin, John, Ibarra, Claudia, Barken, Derren, Dervieux, Thierry
Published in Lupus science & medicine (01.10.2014)
Published in Lupus science & medicine (01.10.2014)
Get full text
Journal Article
Loading…
Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
Gofur, Nanda R.P., Nurdiana, Nurdiana, Kalim, Handono, Handono, Kusworini
Published in Journal of Taibah University Medical Sciences (01.12.2019)
Published in Journal of Taibah University Medical Sciences (01.12.2019)
Get full text
Journal Article
Loading…
Loading…
Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
Lewis, Myles J., Vyse, Simon, Shields, Adrian M., Zou, Lu, Khamashta, Munther, Gordon, Patrick A., Pitzalis, Costantino, Vyse, Timothy J., D’Cruz, David P.
Published in Arthritis research & therapy (08.01.2016)
Published in Arthritis research & therapy (08.01.2016)
Get full text
Journal Article
Loading…
Loading…
Anti-double-stranded DNA antibodies in the healthy elderly: Prevalence and characteristics
Ruffatti, Amelia, Calligaro, Antonia, Del Ross, Teresa, Bertoli, Maria Teresa, Doria, Andrea, Rossi, Laura, Todesco, Sil Vano
Published in Journal of clinical immunology (01.11.1990)
Published in Journal of clinical immunology (01.11.1990)
Get full text
Journal Article
Loading…
Loading…
Skin denervation and cutaneous vasculitis in systemic lupus erythematosus
Tseng, Ming-Tsung, Hsieh, Song-Chou, Shun, Chia-Tung, Lee, Kuang-Lun, Pan, Chun-Liang, Lin, Whei-Min, Lin, Yea-Hui, Yu, Chia-Li, Hsieh, Sung-Tsang
Published in Brain (London, England : 1878) (01.04.2006)
Published in Brain (London, England : 1878) (01.04.2006)
Get full text
Journal Article
Loading…
Loading…
Fcγ receptor IIIA polymorphism in Korean patients with systemic lupus erythematosus
Lee, Eun, Lee, Yun, Baek, Han, Kang, Seong, Chung, Eun, Shin, Chang, Hong, Kyeong, Tsao, Betty P., Hahn, Bevra H., Song, Yeong
Published in Rheumatology international (01.04.2002)
Published in Rheumatology international (01.04.2002)
Get full text
Journal Article
Loading…
Loading…
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
Furie, R A, Leon, G, Thomas, M, Petri, M A, Chu, A D, Hislop, C, Martin, R S, Scheinberg, M A
Published in Annals of the rheumatic diseases (01.09.2015)
Published in Annals of the rheumatic diseases (01.09.2015)
Get full text
Journal Article
Loading…
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
Merrill, Joan T, Shanahan, William R, Scheinberg, Morton, Kalunian, Kenneth C, Wofsy, David, Martin, Renee S
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Loading…
Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus
Hevia, Arancha, Milani, Christian, López, Patricia, Cuervo, Adriana, Arboleya, Silvia, Duranti, Sabrina, Turroni, Francesca, González, Sonia, Suárez, Ana, Gueimonde, Miguel, Ventura, Marco, Sánchez, Borja, Margolles, Abelardo
Published in mBio (30.09.2014)
Published in mBio (30.09.2014)
Get full text
Journal Article
Loading…